ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

计划入组 141 人 · 首次发布于 2016 年 2 月 3 日

ENERGI-F701 for Female Hair Loss Treatment

计划入组 67 人 · 首次发布于 2017 年 11 月 22 日

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

计划入组 230 人 · 首次发布于 2023 年 7 月 5 日

ENERGI-F704

ENERGI-F706

ENERGI-F707

THERACOS HOLDINGS LIMITED

Ireland

HBMI HOLDINGS LIMITED

New Zealand

VIEWBEST HOLDINGS LIMITED

Hong Kong, China

VivoPower Advances in $180 Million Takeover Deal with Energi Holdings as Phase I Due Diligence Completes

Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for Diabetic Foot Ulcer Candidate ENERGI-F703DFU

Energenesis Biomedical Advances First-in-Class Parkinson's Disease Therapy ENERGI-F705PD Toward Phase I Data Readout